|
|
|
|
|
|
|
||
| ||||||||||||||||||||||||||
Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20072416
Machado et al. • Figure S1 TRAF2 and TRAF6 are molecular targets for LX-mediated, SOCS2-dependent inhibition of TLR and TNFR family signaling.
• Figure S2 Late in vivo treatment with PR11 during lymphocytic choriomeningitis virus LCMV infection does not affect the priming of LCMV-specific CD8+ T cells.
• Figure S3 Cytokine expression in the presence of proteasome inhibition during infection with T. gondii.
• Figure S4 Brain.
• Figure S5 Brain.
• Figure S6 Spleen.
• Figure S7 Spleen.
• Figure S8 Brain.
• Figure S9 Brain.
• Figure S10 Proteasome inhibition blocks ATL-induced SOCS2 antiinflammatory actions in vivo.
• Figure S11 Aspirin-induced SOCS2 targets TRAF2 and blocks p50 and p65 translocation to the nucleus after LPS stimulation.
| ||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|
